
Sign up to save your podcasts
Or


One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150
By Michael Putman4.9
113113 ratings
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150

322 Listeners

498 Listeners

876 Listeners

131 Listeners

1,145 Listeners

121 Listeners

191 Listeners

172 Listeners

67 Listeners

248 Listeners

4 Listeners

183 Listeners

11 Listeners

18 Listeners

6 Listeners